Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.3.1.900
Consolidated Statements of Operations - USD ($)
12 Months Ended
Apr. 30, 2015
Apr. 30, 2014
Apr. 30, 2013
Revenues:      
Product sales $ 0 $ 0 $ 12,160
Total revenue 0 0 12,160
Cost of revenues 0 0 9,620
Gross margin 0 0 2,540
Expenses:      
Sales and marketing 230,500 872,200 106,413
Research and development costs 3,476,912 323,500 0
Compensation expense 6,489,334 13,609,995 678,707
Director fees 18,000 768,000 0
Legal and professional fees 884,346 1,487,668 284,510
General and administrative 2,161,643 1,917,779 617,271
Total operating expenses 13,260,735 18,979,142 1,686,901
Loss from operations (13,260,735) (18,979,142) (1,684,361)
Other income (expense):      
Gain on forgiveness of debt 0 1,633,380 277,085
Loss on conversion of preferred stock 0 (5,895,000) 0
Loss on settlement of debt 0 (3,993,295) (39,000)
Gain on settlements 3,337,967 0 0
Other income 0 0 2,590
Interest expense, net (4,938) (19,963) (154,416)
Total other income (expense), net 3,333,029 (8,274,878) 86,259
Net loss $ (9,927,706) $ (27,254,020) $ (1,598,102)
Basic and diluted loss per share $ (.01) $ (0.05) $ 0.00
Weighted average shares outstanding basic and diluted 704,327,656 583,219,665 440,954,850